Tapewire

OTC · USD

VYCO

VYCOR MEDICAL INC

Export transactions ↓
Tapewire entity
8497
SEC CIK
0001424768
Parsed reports
85

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2018 Filed Jul 11, 2018 21:29 UTC OtherCommon Stock 340,909 $0.33 $112,499.97
Disclosure

SEC source: 0001493152-18-009905 · form4.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,381,165

F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2018.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 14:32 UTC
ZACHARIOU PETER CDirector · Chief Executive Officer
OtherWarrant · Derivative 161,598 $0.43 Strike: $0.30 $69,487.14
Disclosure

SEC source: 0001493152-18-005697 · form4.xml · derivative · entry 4

ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 161,598 shares

Expires 2020-08-04

F1 · kind: Cashless exercise of 161,598 Warrants to purchase common stock at $0.30 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 14:32 UTC
ZACHARIOU PETER CDirector · Chief Executive Officer
OtherCommon Stock 48,856 $0.43 $21,008.08
Disclosure

SEC source: 0001493152-18-005697 · form4.xml · nonDerivative · entry 1

ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,856

F1 · kind: Cashless exercise of 161,598 Warrants to purchase common stock at $0.30 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherWarrant · Derivative 1,924,697 $0.43 Strike: $0.30 $827,619.71
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · derivative · entry 10

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,924,697 shares

Expires 2020-01-10

F4 · kind: Cashless exercise of 1,924,697 Warrants to purchase common stock at $0.27 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherWarrant · Derivative 351,204 $0.43 Strike: $0.27 $151,017.72
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · derivative · entry 9

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 351,204 shares

Expires 2020-02-22

F3 · kind: Cashless exercise of 351,204 Warrants to purchase common stock at $0.27 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherWarrant · Derivative 438,053 $0.43 Strike: $0.27 $188,362.79
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · derivative · entry 8

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 438,053 shares

Expires 2022-08-04

F2 · kind: Cashless exercise of 438,053 Warrants to purchase common stock at $0.30 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 716,167 $0.43 $307,951.81
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 6

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,040,256

F4 · kind: Cashless exercise of 1,924,697 Warrants to purchase common stock at $0.27 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 130,681 $0.43 $56,192.83
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 5

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,324,089

F3 · kind: Cashless exercise of 351,204 Warrants to purchase common stock at $0.27 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 132,435 $0.43 $56,947.05
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 4

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,193,408

F2 · kind: Cashless exercise of 438,053 Warrants to purchase common stock at $0.30 per share.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 234,375 $0.48 $112,500.00
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 3

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,060,973

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 54,055 $0.37 $20,000.35
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,826,598

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 18:40 UTC OtherCommon Stock 401,786 $0.28 $112,500.08
Disclosure

SEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 1

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,772,543

F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively.

Read SEC document
April 01, 2018 Filed Apr 4, 2018 13:11 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 14,583 $0.48 $6,999.84
Disclosure

SEC source: 0001493152-18-004740 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,769

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2018 Filed Apr 4, 2018 17:12 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 14,583 $0.48 $6,999.84
Disclosure

SEC source: 0001493152-18-004741 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,305

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2018 Filed Apr 4, 2018 17:10 UTC OtherVycor Medical Inc. Common Stock par value $0.001 14,583 $0.48 $6,999.84
Disclosure

SEC source: 0001493152-18-004739 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,268

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
February 01, 2018 Filed Feb 10, 2018 00:59 UTC GrantCommon Stock par value $0.0001 250,000 $0.37 $92,500.00
Disclosure

SEC source: 0001493152-18-001780 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,370,757

F1 · shares: Issued pursuant to Fountain head Consultancy Agreement

Read SEC document
January 01, 2018 Filed Jan 3, 2018 12:45 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 18,919 $0.37 $7,000.03
Disclosure

SEC source: 0001493152-18-000081 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,186

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 17:48 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 18,919 $0.37 $7,000.03
Disclosure

SEC source: 0001493152-18-000083 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,722

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 17:45 UTC OtherVycor Medical Inc. Common Stock par value $0.001 18,919 $0.37 $7,000.03
Disclosure

SEC source: 0001493152-18-000080 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,685

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
October 01, 2017 Filed Oct 6, 2017 15:15 UTC OtherVycor Medical Inc. Common Stock par value $0.0001 25,000 $0.28 $7,000.00
Disclosure

SEC source: 0001493152-17-011379 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,267

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
September 30, 2017 Filed Oct 6, 2017 19:12 UTC OtherVycor Medical Inc. Common Stock par value $0.001 25,000 $0.28 $7,000.00
Disclosure

SEC source: 0001493152-17-011378 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,766

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

F2 · balance_after: Includes a 10,000 share adjustment due to a calculation error on the prior report.

Read SEC document
September 30, 2017 Filed Oct 6, 2017 19:10 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 25,000 $0.28 $7,000.00
Disclosure

SEC source: 0001493152-17-011377 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,803

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
August 05, 2017 Filed Sep 15, 2017 15:02 UTC
ZACHARIOU PETER CDirector · Chief Executive Officer
OtherWarrant · Derivative 161,598 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001493152-17-010660 · form4.xml · derivative · entry 3

ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,598

Underlying: Common Stock · 161,598 shares

Expires 2020-08-04

F1 · kind: Warrants issued pursuant to Share Exchange Agreement dated August 5, 2014

Read SEC document
August 05, 2017 Filed Sep 15, 2017 19:05 UTC OtherWarrant · Derivative 438,053 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001493152-17-010662 · form4.xml · derivative · entry 6

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,053

Underlying: Common Stock · 438,053 shares

Expires 2022-08-04

F2 · kind: Warrants issued pursuant to Share Exchange Agreement dated August 5, 2014.

Read SEC document
August 05, 2017 Filed Feb 10, 2018 00:59 UTC OtherWarrant · Derivative 438,053 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001493152-18-001780 · form4.xml · derivative · entry 6

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,053

Underlying: Common Stock · 438,053 shares

Expires 2022-08-04

Read SEC document
July 01, 2017 Filed Jul 21, 2017 15:37 UTC OtherVycor Medical Inc. Common Stock pure value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-008079 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,267

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

F2 · balance_after: Includes an adjustment of 7,387 shares based upon a calculation error in the reporting person's report as of October 31, 2016.

Read SEC document
June 30, 2017 Filed Jul 21, 2017 19:41 UTC GrantCommon Stock par value $0.0001 501,429 $0.21 $105,300.09
Disclosure

SEC source: 0001493152-17-008081 · form4.xml · nonDerivative · entry 3

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,120,757

F1 · shares: Issuance Pursuant to Fountainhead Consultancy Agreement.

Read SEC document
June 30, 2017 Filed Jul 21, 2017 19:39 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-008080 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,803

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

F2 · balance_after: Includes an adjustment of 300 shares based upon a calculation error in the reporting person's report as of December 31, 2016.

Read SEC document
June 30, 2017 Filed Jul 21, 2017 19:35 UTC OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-008077 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,766

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
April 30, 2017 Filed Jul 21, 2017 19:41 UTC GrantCommon Stock par value $0.0001 1,571,429 $0.21 $330,000.09
Disclosure

SEC source: 0001493152-17-008081 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619,328

F1 · shares: Issuance Pursuant to Fountainhead Consultancy Agreement.

Read SEC document
April 01, 2017 Filed Apr 6, 2017 15:55 UTC OtherVycor Medical Inc. Common Stock pure value $0.0001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-003586 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,547

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2017 Filed Apr 6, 2017 20:03 UTC GrantCommon Stock par value $0.0001 142,857 $0.21 $29,999.97
Disclosure

SEC source: 0001493152-17-003591 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,047,899

F1 · shares: Payment of consulting fee in stock.

Read SEC document
March 31, 2017 Filed Apr 6, 2017 19:59 UTC OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-003589 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,433

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2017 Filed Apr 6, 2017 19:51 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 33,333 $0.21 $6,999.93
Disclosure

SEC source: 0001493152-17-003584 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,170

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
March 31, 2017 Filed Apr 11, 2017 10:15 UTC Amendment GrantOption · Derivative 660,000 $0.27 Strike: $0.27 $178,200.00
Disclosure

SEC source: 0001493152-17-003717 · form4a.xml · derivative · entry 10

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 660,000

Underlying: Common Stock · 660,000 shares

Expires not disclosed

F1 · date: Grant of option on March 31, 2017. Option vesting is subject to achievement of certain milestones prior to March 31, 2018.

F2 · derivative.exercise_date: Exercisable upon achievement of certain milestones prior to March 31, 2018 for a period of three years from date of vesting.

F2 · derivative.expiration_date: Exercisable upon achievement of certain milestones prior to March 31, 2018 for a period of three years from date of vesting.

Read SEC document
March 31, 2017 Filed Apr 11, 2017 10:15 UTC Amendment GrantCommon Stock par value $0.0001 142,857 $0.21 $29,999.97
Disclosure

SEC source: 0001493152-17-003717 · form4a.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,047,899

Read SEC document
February 23, 2017 Filed Mar 2, 2017 22:20 UTC OtherWarrant · Derivative 351,204 $0.00 Strike: $0.27 $0.00
Disclosure

SEC source: 0001493152-17-002076 · form4.xml · derivative · entry 9

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,204

Underlying: Common Stock · 351,204 shares

Expires 2010-02-22

F1 · kind: Acquired in connection with purchase of 351,204 shares of common stock in a private placement by the issuer.

Read SEC document
February 23, 2017 Filed Mar 2, 2017 22:20 UTC GrantCommon Stock par value $0.0001 351,204 $0.21 $73,752.84
Disclosure

SEC source: 0001493152-17-002076 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,905,042

Read SEC document
January 11, 2017 Filed Jan 19, 2017 22:40 UTC OtherWarrant · Derivative 1,924,697 $0.00 Strike: $0.27 $0.00
Disclosure

SEC source: 0001493152-17-000652 · form4.xml · derivative · entry 8

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,924,697

Underlying: Common Stock · 1,924,697 shares

Expires 2020-01-10

F1 · kind: Acquired in connection with purchase of 1,924,697 shares of common stock in a private placement by the issuer.

Read SEC document
January 11, 2017 Filed Jan 19, 2017 22:40 UTC GrantCommon Stock par value $0.0001 1,924,697 $0.21 $404,186.37
Disclosure

SEC source: 0001493152-17-000652 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,553,838

Read SEC document
January 01, 2017 Filed Jan 13, 2017 14:03 UTC OtherVycor Medical Inc. Common Stock pure value $0.0001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-17-000450 · form4.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,214

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2016 Filed Jan 13, 2017 19:04 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-17-000452 · form4.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,837

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
December 31, 2016 Filed Jan 13, 2017 19:01 UTC GrantCommon Stock par value $0.0001 90,909 $0.33 $29,999.97
Disclosure

SEC source: 0001493152-17-000448 · form4.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,629,141

Read SEC document
December 31, 2016 Filed Jan 13, 2017 18:45 UTC OtherVycor Medical Inc. Common Stock par value $0.001 21,212 $0.33 $6,999.96
Disclosure

SEC source: 0001493152-17-000444 · form4.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,100

F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director.

Read SEC document
October 01, 2016 Filed Oct 7, 2016 13:57 UTC OtherVycor Medical Inc. Common Stock pure value $0.0001 20,588 $0.34 $6,999.92
Disclosure

SEC source: 0001354488-16-008370 · issuerdirect_section16.xml · nonDerivative · entry 1

GIRGENTI STEVEN · CIK 0001055530 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,002

Read SEC document
September 30, 2016 Filed Oct 7, 2016 17:56 UTC
Rush LowellDirector
OtherVycor Medical Inc. Common Stock par value $0.001 20,588 $0.34 $6,999.92
Disclosure

SEC source: 0001354488-16-008369 · issuerdirect_section16.xml · nonDerivative · entry 1

Rush Lowell · CIK 0001595155 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,925

Read SEC document
September 30, 2016 Filed Oct 7, 2016 17:54 UTC OtherVycor Medical Inc. Common Stock par value $0.001 20,588 $0.34 $6,999.92
Disclosure

SEC source: 0001354488-16-008368 · issuerdirect_section16.xml · nonDerivative · entry 1

Bronsther Oscar · CIK 0001543826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,888

Read SEC document
September 30, 2016 Filed Oct 11, 2016 20:51 UTC GrantCommon Stock par value $0.0001 88,235 $0.34 $29,999.90
Disclosure

SEC source: 0001354488-16-008378 · issuerdirect_section16.xml · nonDerivative · entry 2

FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,538,232

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.